Retatrutide in Australia: A Promising Hope for Weight Loss ?
Australia is currently observing the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist , representing a significant advance in addressing excess weight. Early clinical trials have demonstrated impressive results, showing greater efficacy than existing treatments like semagl